Eiman Musleh, Registered Nurse - Oncology Medicare: Not Enrolled in Medicare Practice Location: 195 Waukegan Rd Unit 252, Glenview, IL 60025 Phone: 847-445-3231 |
Samantha Marie Long, MASTERS Registered Nurse Medicare: Medicare Enrolled Practice Location: 2150 Pfingsten Rd Ste 1200, Glenview, IL 60026 Phone: 847-864-3278 |
Kimberly Graf, FNP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2551 Compass Rd Ste 105, Glenview, IL 60026 Phone: 847-901-0252 Fax: 847-901-0273 |
News Archive
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
While primarily a respiratory illness, there are distinctive alterations in the type and number of blood cells in COVID-19. A new study by a team of researchers in Germany describes the nature of these changes.
TennCare, the plan enacted in the mid-1990s to cover the Tennessee's uninsured through a public insurance program which nearly bankrupted the state, is fueling national debate about a public option, The Wall Street Journal reports.
Scientists have identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice.
When COVID-19 first shut down classrooms and virtual schooling became the new norm, ophthalmologists predicted an increase in digital eye strain in children.
› Verified 2 days ago